
The study was conducted using 195 randomly selected medical questions posted to Reddit r/AskDocs, an online social media forum where users can post medical questions and verified health care professionals submit answers.

The study was conducted using 195 randomly selected medical questions posted to Reddit r/AskDocs, an online social media forum where users can post medical questions and verified health care professionals submit answers.

Contemporary Pediatrics® Editorial Advisory Board member Andrew Schuman, MD, clinical assistant professor of pediatrics, Geisel School of Medicine, Dartmouth, discusses whether infant sleep systems are needed for a safe sleeping environment.

Autism prevalence has been an increasing trend even before the COVID-19 pandemic, says J. Thomas Megerian, MD, PhD, FAAP, clinical director, Thompson Autism and Neurodevelopmental Center, Children's Hospital of Orange County. In this Contemporary Pediatrics® interview, watch as he discusses this trend and speaks to the importance of early autism intervention.

In a recent study, centers performing open spina bifida repair saw variations in policies for fetal resuscitation.

In this Contemporary Pediatrics® interview, Jamie Alan, RPh, PharmD, PhD, associate professor, Department of Pharmacology and Toxicology, Michigan State University, talks about the potential impacts red dye No. 3 has on children, and why an assembly bill in California is trying to eliminate it.

According to the study, gay and bisexual adolescents show higher rates of sleep issues and sleep disturbances.

At the 2023 Pediatric Academic Societies meeting, held in Washington, DC, from April 27 to May 1, 2023, the impact that air pollution and climate change has on infants was discussed.

With the recent FDA-approved indication for children aged 2.5 years and older, somapacitan-beco is the first and only once-weekly growth hormone (GH) for children and adults.

Reasons why primary care should incorporate the Rapid Interactive Screen Test for autism spectrum disorder were presented during a session at the 2023 Pediatric Academic Societies Meeting held in Washington, DC.

At the 2023 Pediatric Academic Societies Meeting, presenters provided the benefits of breastfeeding, along with some useful tips for lactation and how to best help your breastfeeding patients.

According to Pfizer, the company’s pneumococcal conjugate vaccine Prevnar 20 has been approved by the FDA to treat infants and children aged 6 weeks to 17 years for the prevention of invasive pneumococcal disease (IPD).

Contemporary Pediatrics® Editorial Advisory Board Member Steven Selbst, MD, gives a glimpse into some research he was involved in regarding physician burnout at the 2023 Pediatric Academic Societies meeting.

Minoryx's leriglitazone showed a decrease in matrix metalloproteinase-9 concentrations in pediatric patients with cerebral adrenoleukodystrophy, according to a 24-week analysis.

Rana Hamdy, MD, discusses being co-chair of a diagnostic stewardship symposium at the 2023 Pediatric Academic Societies meeting, held in Washington, DC from April 27 to May 1.

According to a phase 2 study, remission of macrophage activation syndrome (MAS) secondary to systemic juvenile idiopathic arthritis (sJIA) or adult-onset Still’s disease (AOSD) was achieved in patients taking emapalumab who failed high-dose glucocorticoids.

Contemporary Pediatrics® Editorial Advisory Board Member Steven Selbst, MD, discusses what sessions he is looking forward to the most from this year's Pediatric Academic Societies conference in Washington, DC.

Erica Sood, PhD, Nemours Children’s Health pediatric psychologist, discusses her workshop focused on improving the emotional health of children with chronic conditions, which will be presented at the 2023 Pediatric Academic Societies meeting held in Washington, DC from April 27 to May 1.

In addition, 17 female patients who completed PENFS showed improvements in various symptoms, such as pain, disability, and catastrophizing, while carbohydrate degradation and LCFA synthesis pathways decreased in the post-treatment and follow-up analysis.

Qualitative findings show children with sickle cell disease have the desire to feel normal and utilize personal strengths to manage their condition.

An analysis of 118 infant eyes in India suggests the biosimilar is safe and effective in treating ROP, with about one-third of eyes requiring reinjection at 7 weeks after the first dose.

Suspected self-poisoning suicide attempts increased 73% for children aged 10 to 12 years and 30% for those aged 10 to 19 years in 2021 compared to 2019, according to a Morbidity and Mortality Weekly Report (MMWR) from the CDC.

Not forcing affection, using appropriate language, and controlling media exposure are just some of the American Academy of Pediatrics’ tips for teaching children about body boundaries and safety.

Results show a high level of adherence to hydroxyurea medication is essential for lowering the incidence of negative clinical outcomes like VOCs and acute chest syndrome in children with sickle cell anemia.

In a recent review, recent eviction was associated with worse child health outcomes.

Andrew Lam, MD, retinal surgeon, author, assistant professor, University of Massachusetts Medical School explains what readers can look forward to in his new book, "The Masters of Medicine: Our Greatest Triumphs in the Race to Cure Humanity’s Deadliest Diseases."

There are mixed feelings when it comes to teenagers having a job, according to over 1000 parents surveyed in a recent C.S. Mott Children’s Hospital National Poll.

Due to possible undeclared cashews in SimplyProtein’s Peanut Butter Chocolate Crispy Bars, the voluntary recall of the Costco-sold product has been expanded.

A cross-sectional, case-controlled cohort study evaluated the cardiorespiratory and neuromuscular fitness of Finnish patients with JIA and healthy controls.

Check out the latest news, notes, and headlines from the National Association of Pediatric Nurse Practitioners 44th National Conference on Pediatric Health Care, held March 15-18, 2023, in Orlando, Florida.

A retrospective analysis of more than 60 patients 21 years or younger who received a transcatheter leadless pacemaker provides an overview of the safety of such an approach in younger patient populations.